Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.69 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.56 |
| ▸ | CASP2 | P42575 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3907996 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL9469574 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL9251708 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL9471032 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL4165911 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL9034010 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL15058976 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL1029118 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL4177813 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 | |
| SCHEMBL11720611 | 1.00 | FAAH (0.69) | FAAHHSP90AA1DNM1CASP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0463485-B1 | Process for the production of flexographic relief printing plates | BASF AG (DE) | 1997-05-02 | — | — | EP | claimed |
| EP-0316618-B1 | Multilayer flat light sensitive registration material | BASF AG (DE) | 1994-08-17 | — | — | EP | claimed |
| EP-0463485-A2 | Process for the production of flexographic relief printing plates | BASF Aktiengesellschaft (DE) | 1992-01-02 | — | — | EP | claimed |
| US-5035981-A | Having a top layer of high-strength, transparent, soluble or swellable polymer containing an antistatic agent of an ethoxylated amine or amide; exposure; development | BASF AKTIENGESELLSCHAFT (DE) | 1991-07-30 | — | — | US | claimed |
| US-4946758-A | RELIEF IMAGE FORMING LAYER; HIGH TENSILE STRENGTH POLYMER AND COVERING | BASF AKTIENGESELLSCHAFT (DE) | 1990-08-07 | — | — | US | claimed |
| EP-0316618-A2 | Multilayer flat light sensitive registration material | BASF Aktiengesellschaft (DE) | 1989-05-24 | — | — | EP | claimed |
| CN-107205401-A | Microbiocidal control in poultry processing | 雅宝公司 | 2017-09-26 | — | — | CN | disclosed |
| US-7067620-B2 | Antibacterial agents | THERAVANCE, INC. (US) | 2006-06-27 | — | — | US | disclosed |
| US-20050171010-A1 | NOVEL ANTIBACTERIAL AGENTS | CUMBERLAND PHARMACEUTICALS INC. | 2005-08-04 | — | — | US | disclosed |
| US-6518242-B1 | Derivatives of glycopeptide antibacterial agents | THERAVANCE, INC. | 2003-02-11 | — | — | US | disclosed |
| EP-1060189-A1 | DERIVATIVES OF GLYCOPEPTIDE ANTIBACTERIAL AGENTS | Advanced Medicine, Inc. (US) | 2000-12-20 | — | — | EP | disclosed |
| WO-1999042476-A1 | NOVEL ANTIBACTERIAL AGENTS | ADVANCED MEDICINE, INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| EP-0463485-B1 | Process for the production of flexographic relief printing plates | BASF AG (DE) | 1997-05-02 | — | — | EP | disclosed |
| EP-0316618-B1 | Multilayer flat light sensitive registration material | BASF AG (DE) | 1994-08-17 | — | — | EP | disclosed |
| US-5240815-A | Exposing photopolymerizable component to actinic light, development | BASF AKTIENGESELLSCHAFT (DE) | 1993-08-31 | — | — | US | disclosed |
| EP-0463485-A2 | Process for the production of flexographic relief printing plates | BASF Aktiengesellschaft (DE) | 1992-01-02 | — | — | EP | disclosed |
| US-5035981-A | Having a top layer of high-strength, transparent, soluble or swellable polymer containing an antistatic agent of an ethoxylated amine or amide; exposure; development | BASF AKTIENGESELLSCHAFT (DE) | 1991-07-30 | — | — | US | disclosed |
| US-4946758-A | RELIEF IMAGE FORMING LAYER; HIGH TENSILE STRENGTH POLYMER AND COVERING | BASF AKTIENGESELLSCHAFT (DE) | 1990-08-07 | — | — | US | disclosed |
| EP-0316618-A2 | Multilayer flat light sensitive registration material | BASF Aktiengesellschaft (DE) | 1989-05-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050171010-A1 | NOVEL ANTIBACTERIAL AGENTS | ENGASE, GALE, MGAM | FAAH 2785/4885HSP90AA1 594/4885DNM1 1429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.